JANA BAXTER: Open Payments
NPI 1780915777 · DUNCANVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,415 in 81 payments from 18 companies in 2025. Trend: 2023 $1,319 · 2024 $1,140 · 2025 $1,415
Food & beverage: $1,415
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $327 |
| Lundbeck LLC | 8 | $151 |
| Novo Nordisk Inc | 7 | $146 |
| Lilly USA, LLC | 11 | $141 |
| Corcept Therapeutics | 5 | $116 |
| Axsome Therapeutics, Inc. | 4 | $76 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
Products named: VRAYLAR, REXULTI, Korlym, MOUNJARO, Ozempic, Auvelity, TRELEGY ELLIPTA, CAPLYTA.
Industry payments across TX — which companies pay providers there.
